Search results
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 4 hours agoThe highly anticipated ASPEN trial (NCT04594369) was a global, randomised, double-blind,...
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
Clinical Trials Arena via Yahoo Finance· 3 hours agoSOTIO Biotech has dosed the first subject in its Phase I clinical trial VICTORIA-01 to assess the...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies
Clinical Trials Arena via Yahoo Finance· 3 hours agoIn January, IGC Pharma announced the dosing of the first patient at ClinCloud, a new clinical...
Where Will Amgen Be in 3 Years?
The Motley Fool via AOL· 2 hours agoAside from its biosimilar medicines, Amgen has 28 programs currently in phase 3 clinical trials. Most of those are investigating whether ...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 5 hours agoMerck has reported that its Phase III KEYNOTE-522 clinical trial of KEYTRUDA to treat high-risk,...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 1 day agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical ...
BMS stakes $80m on Prothena’s neurodegenerative candidate
Pharmaceutical Technology via Yahoo Finance· 1 hour agoThe biotech cited higher R&D and G&A expenses in 2023 compared to the previous year. Prothena’s most...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 1 day agoPhase 2, Proof-of-Concept X-NOVA Study” May 29, 2024 at 11:15 am to 1 pm ET in Salon 4 The Company’s presentations summarize clinical ...
Insmed shares double as lung drug data convince Wall Street
BioPharma Dive via Yahoo Finance· 1 day agoAfter reporting positive clinical trial results for its drug brensocatib, Insmed plans to later this...
